Domestic drugmakers seeking expansion of overseas market

Published: 2007-03-30 07:00:00

Updated: 2007-03-30 07:00:00

With the domestic pharmaceutical industry facing the imminent settlement of a free trade agreement between Korea and the United States and an ongoing drug pricing policy (so-called positive list system), drug manufacturers in Korea is stepping up their aggressive export drive towards on foreign m...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK